Serotype C and D of Clostridium botulinum produce botulinum toxin complex (TC), which is comprised of botulinum neurotoxin, nontoxic nonhemagglutinin, and hemagglutinins (HAs). The TC is capable of aggregating equine erythrocytes via interaction between one of the HAs, namely HA-33, and sugar chains on the cell surface. This hemagglutination is inhibited by specific sugars. In this data article, we used four TCs from serotype C and D strains. The hemagglutination-inhibiting effects of 18 sugars and 8 glycoproteins were studied. The purified TC was mixed with the sugar to enable binding of the sugar to the TC; then, the erythrocytes were added to the mixture. Specific binding between the sugar and TC resulted in inhibition of cell aggregation. Here, data illustrating the inhibitory effects of various sugars and glycoproteins against
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Data
Here, we present data illustrating the inhibitory effects of 18 sugars and 8 glycoproteins (listed in Table 1 ) on hemagglutination by L-TC, a complex of the botulinum neurotoxin (BoNT), nontoxic nonhemagglutinin (NTNHA), and three types of hemagglutinin subcomponents (HA-70, HA-17, and HA-33), produced by the C. botulinum serotype C strain Stockholm (C-St), Yoichi (C-Yoichi), D strain CB-16 (D-CB16), and 1873 (D-1873).
Experimental design
L-TC was purified from the culture of C. botulinum C-St [1] , C-Yoichi [2] , D-CB16 [3] , and D-1873 [4] as described in the cited studies. Of the L-TC components, the BoNT also binds to the cells via sugarrecognition ability [5] . However, the residues essential for the sugar-recognition in the BoNT molecule are covered with other components of the L-TC [6, 7] ; thus the cell binding of the L-TC dominantly depend on the HA-33 components that exposed to the most outside of the molecule [7] . To date, it has been shown that, in the serotypes C and D of C. botulinum, there are at least two types of L-TC containing the HA-33 protein, that preferentially recognize sugar chains with sialic acid moieties (of C-St and D-CB16) or galactose moieties (of C-Yoichi and D-1873) at their termini [2, 4] . Previous studies have shown that C-St and D-CB16 L-TCs exert the hemagglutination activity against equine erythrocytes, whereas C-Yoichi and D-1873 L-TCs exhibited no, or very low, hemagglutination titer against equine erythrocytes. However, C-Yoichi and D-1873 L-TCs were found to exhibit hemagglutination titer against equine erythrocytes treated with neuraminidase [2, 4] . Therefore, normal erythrocytes were used to study hemagglutination by C-St and D-CB16, and neuraminidase-treated erythrocytes were used to study hemagglutination by the C-Yoichi and D-1873 strains.
Materials and methods

SDS-PAGE
SDS-PAGE was performed as described by Laemmli [8] , by using a 13.6% polyacrylamide gel with 2-mercaptoethanol.
Preparation of equine erythrocyte suspension
Erythrocytes in defibrinated equine blood (Kojin Bio, Sakaido, Saitama, Japan) were collected by centrifugation ( 1000 Â g, 5 min, 4°C) (TOMY GRX-220, Tomy Seiko Co., Ltd., Tokyo, Japan) and rinsed with 0.15 M phosphate buffer, pH 7.0. Suspension of the erythrocytes (1%) was prepared with the same buffer. Erythrocytes were treated with Clostridium perfringens neuraminidase (Sigma-Aldrich). Neuraminidase (0.5 U) was added to a 10% equine erythrocyte suspension, and the mix was incubated at 37°C for 1 h. Treated erythrocytes were collected, rinsed, and suspended in 0.15 M phosphate buffer (pH 7.0) to create a 1% suspension. Table 1 Inhibitory effects on hemagglutination by C-St, C-Yoichi, D-CB16, and D-1873 L-TC.
Sugars or glycoproteins
a Neuraminidase-treated erythrocyte was used.
Hemagglutination assay and inhibitory test against hemagglutination
Hemagglutination assay was performed by the microtitration method, using a multiwell titer plate (Nunc A/S, Roskilde, Denmark). Samples (35 ml) of each preparation (100 mg/ml) were diluted in serial two-fold steps with 0.15 M phosphate buffer (pH 7.0) and mixed with an equal volume of a 1% equine erythrocyte suspension. After incubation at 20-25°C for 2 h, the reciprocal hemagglutination titer was determined as 2n.
For the inhibitory test, sugars (D-glucose, D-mannose, galactose, N-acetyl-D-glucosamine, methylα-D-mannoside, L-fucose, xylose, fructose, rhamnose, N-acetyl-D-galactosamine, sucrose, N-acetylneuraminic acid, maltose, cellobiose, lactose, chitin oligomers, N-acetyllactosamine, and chitobiose) and glycoproteins (bovine fetuin, asialofetuin, ovomucoid, ovoalbumin, human transferrin, horseradish peroxidase, yeast invertase, and human α1-acid glycoprotein) were used in this study. The L-TC solution (10 ml, titer 2) was incubated with an equal volume of sugar or glycoprotein solution (final concentration of 5 mg/ml), at room temperature, for 1 h. Thereafter, the solution was incubated with 20 ml of equine erythrocyte suspension (1%) at 37°C for 1 h.
